MedTrace Logo

Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer

NCT00460200 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2012-10-04

No results posted yet for this study

Summary

RATIONALE: Measuring levels of interleukin-6 and depression may help doctors understand the relationship between interleukin-6 and depression. It may also help the study of cancer in the future.

PURPOSE: This clinical trial is studying depression and interleukin-6 production in patients with ovarian epithelial cancer.

Conditions

Interventions

GENETIC

polymorphism analysis

OTHER

laboratory biomarker analysis

OTHER

physiologic testing

OTHER

questionnaire administration

PROCEDURE

conventional surgery

PROCEDURE

fatigue assessment and management

PROCEDURE

psychosocial assessment and care

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Leah Z. Fitzgerald, RN, PhD · Jonsson Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00460200 on ClinicalTrials.gov